Cardiovascular disease (CVD) is responsible for nearly 1 in 3 deaths in the U.S. It claims more lives in the U.S. than all forms of cancer and accidental deaths combined.
CVD is not a single illness. It is a family of diseases that affect the heart and blood vessels, including coronary heart disease (CHD), stroke, heart failure and peripheral artery disease.
CHD often develops silently over many years, and its first symptom may be a heart attack.
cause of hospitalization and adds $13,000 more per year to patient healthcare costs,
U.S. adults aged over 20 years live with coronary heart disease
Americans are affected by Ischemia with No Obstructive Coronary Arteries (INOCA), a subset of CHD
Heart attacks don't always announce themselves. Many occur without chest pain, especially in women and people with diabetes.
is how often someone in the U.S. experiences a heart attack
heart attacks are silent, occurring without warning
is the number of heart attacks occurring annually
of those with CHD do not have traditional risk factors
of suspected ischemia cases reveal no obstructive disease
is the average sensitivity of conventional risk calculators
Our clinical solutions can reveal what traditional methods may miss by assessing a patient's epigenetic and genetic biomarkers. For non-clinical stakeholders, our population-level insights and biopharma research platform turn complex epigenetic and genetic data into clear, actionable insights.
Rx Only FSA/HSA Eligible
Rx Only FSA/HSA Eligible
Uncover population cardiovascular risk profile in real-time. Identify opportunities to reduce healthcare spend.
Discover new cardiovascular biomarkers with AI and epigenetics. Design smarter, more precise clinical trials.
